Division of Pulmonology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
Research Institute, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
BMC Pulm Med. 2021 Jan 19;21(1):32. doi: 10.1186/s12890-021-01391-z.
Early suspicion followed by assessing lung function with spirometry could decrease the underdiagnosis of chronic obstructive pulmonary disease (COPD) in primary care. We aimed to develop a nomogram to predict the FEV/FVC ratio and the presence of COPD.
We retrospectively reviewed the data of 4241 adult patients who underwent spirometry between 2013 and 2019. By linear regression analysis, variables associated with FEV/FVC were identified in the training cohort (n = 2969). Using the variables as predictors, a nomogram was created to predict the FEV/FVC ratio and validated in the test cohort (n = 1272).
Older age (β coefficient [95% CI], - 0.153 [- 0.183, - 0.122]), male sex (- 1.904 [- 2.749, - 1.056]), current or past smoking history (- 3.324 [- 4.200, - 2.453]), and the presence of dyspnea (- 2.453 [- 3.612, - 1.291]) or overweight (0.894 [0.191, 1.598]) were significantly associated with the FEV/FVC ratio. In the final testing, the developed nomogram showed a mean absolute error of 8.2% between the predicted and actual FEV/FVC ratios. The overall performance was best when FEV/FVC < 70% was used as a diagnostic criterion for COPD; the sensitivity, specificity, and balanced accuracy were 82.3%, 68.6%, and 75.5%, respectively.
The developed nomogram could be used to identify potential patients at risk of COPD who may need further evaluation, especially in the primary care setting where spirometry is not available.
在初级保健中,通过早期怀疑和肺功能测定(如肺活量测定)可以减少慢性阻塞性肺疾病(COPD)的漏诊。我们旨在开发一个列线图来预测 FEV/FVC 比值和 COPD 的存在。
我们回顾性分析了 2013 年至 2019 年间接受肺活量测定的 4241 例成年患者的数据。通过线性回归分析,在训练队列(n=2969)中确定了与 FEV/FVC 相关的变量。使用这些变量作为预测因子,创建了一个列线图来预测 FEV/FVC 比值,并在测试队列(n=1272)中进行验证。
年龄较大(β系数[95%CI],-0.153[-0.183,-0.122])、男性(-1.904[-2.749,-1.056])、当前或既往吸烟史(-3.324[-4.200,-2.453])以及呼吸困难(-2.453[-3.612,-1.291])或超重(0.894[0.191,1.598])与 FEV/FVC 比值显著相关。在最终的测试中,开发的列线图在预测和实际 FEV/FVC 比值之间的平均绝对误差为 8.2%。当 FEV/FVC<70% 被用作 COPD 的诊断标准时,该列线图的整体性能最佳;其灵敏度、特异性和平衡准确性分别为 82.3%、68.6%和 75.5%。
该列线图可用于识别可能需要进一步评估的潜在 COPD 风险患者,尤其是在无法进行肺活量测定的初级保健环境中。